CRXX: advisory panel 9-23-09; (see Nov. for PDUFA details)
ACHN http://finance.yahoo.com/q?s=achn
Price: 1.99 (8-11-09)
52 wk range: .65 (12-31-08) to 3.00 (8-21-08)
Upcoming event: safety and tolerability data for Phase I HCV trail (late summer); efficacy data (winter 09)
Thoughts: Phase I too early, not a good buy (AG)
PARS.PK http://finance.yahoo.com/q?s=PARS.PK
Price: .46 (8-11-09)
52 wk range: .02 (3-20-09) to .48 (8-11-09)
Upcoming event: Results from Phase IIb trial expected Sept. 09
Thoughts: maybe good buy; already missed out on 2,000% in the last 3 months (AG)
ENDP http://finance.yahoo.com/q?s=endp
Price: 21.06 (8-11-09)
52 wk range: 13.87 (10-10-08) to 26.14 (1-2-09)
Upcoming event: PDUFA 9-2-09
Thoughts: too big (AG)
SLXP http://finance.yahoo.com/q?s=slxp
Price: 12.54 (8-11-09)
52 wk range: 5.07 (10-10-08) to 13.26 (7-26-09)
Upcoming event : PDUFA 9-11-09
Thoughts: too late? (AG)
Tuesday, August 11, 2009
Subscribe to:
Post Comments (Atom)
After looking at all the picks, I think the best two to get into right now seems like CRXX and MSHL.
ReplyDeleteJust my thoughts
Henok